Tax Season is Here! Save 15% on H&R Block Online
iconAll times are GMT -4. The time now is 08:15 PM. | Search:

» StockRants Stock Forum » Public Stock Forums » US Stock Picks » Buy: CTXR-Citius Pharmaceuticals - submitted a preIND to FDA under Corona Virus treatment



Reply
 
Thread Tools Search this Thread
Old 05-16-2020, 12:55 PM   Nav to Top  #1
antsrants
Senior Trader
 
antsrants's Avatar
 
Join Date: Aug 2017
Location: Frankfurt
Posts: 185
Favorites: USAS, CTXR, MQR, LTBR, PYR
Rep Power: 41
Reputation: 16
antsrants is on a distinguished road
Default CTXR-Citius Pharmaceuticals - submitted a preIND to FDA under Corona Virus treatment

CTXR is a Biotech company with a very promising product pipeline. Besides this, CTXR recently submitted a pre-IND to the FDA under the Coronavirus Treatment.

Currently CTXR is trading lower as they have announced a $7.5 Million Offering at $1. I think it is a good entry point.

Recent Company Highlights include:

- Submitting a pre-IND to the FDA under the Coronavirus Treatment Acceleration Program (CTAP) for a novel stem-cell therapy to treat ARDS associated with COVID-19
- Obtaining an exclusive option from Novellus, Inc. to license a stem-cell therapy to treat ARDS associated with COVID-19
- Achieving 50% patient enrollment in the Phase 3 Mino-Lok® pivotal trial
- Passing the interim futility analysis successfully in the ongoing Phase 3 trial of Mino-Lok vs. standard-of-care antibiotic locks


https://www.citiuspharma.com/wp-cont...tter_final.pdf
antsrants is offline   Rate this post Yes | No Reply With Quote
Old 05-16-2020, 03:46 PM   Nav to Top  #2
antsrants
Senior Trader
 
antsrants's Avatar
 
Join Date: Aug 2017
Location: Frankfurt
Posts: 185
Favorites: USAS, CTXR, MQR, LTBR, PYR
Rep Power: 41
Reputation: 16
antsrants is on a distinguished road
Thread Starter
Default

Besides their recently submitted pre-IND to the FDA under the Coronavirus Treatment, in particular the late stage lead asset of CTXR is very promising. It is called Mino-Lok and is mid-way through Phase 3 and has favorable review received with a huge market potential.

Mino-Lok
- Mid-way through Phase 3; Favorable review received from Futility Analysis by Independent Review Board
- Mino-Lok is the first –and only –therapy under investigation that can be used to sterilize and salvage the infected CVC avoiding the complications, discomfort and costs of removal and replacement.
- Large Market Need: Market estimated to be >$1.8 B worldwide; current SOC is dangerous and costly
- Competitive Landscape: There are no products being developed for treatmentof infected central venous lines.

CTXR Presentation - Summer 2020
May 12, 2020
https://ir.citiuspharma.com/presentations
antsrants is offline   Rate this post Yes | No Reply With Quote
Old 05-17-2020, 02:38 AM   Nav to Top  #3
antsrants
Senior Trader
 
antsrants's Avatar
 
Join Date: Aug 2017
Location: Frankfurt
Posts: 185
Favorites: USAS, CTXR, MQR, LTBR, PYR
Rep Power: 41
Reputation: 16
antsrants is on a distinguished road
Thread Starter
Default

Citius Announces Data on NoveCite Mesenchymal Stem Cells (NC-MSCs) to be Presented at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting
May 13, 2020

"Last month Citius signed an exclusive option agreement with Novellus for worldwide development and commercial rights related to the use of these uniquely derived MSCs for the treatment of ARDS. The pre-clinical data that is being presented at the ASGCT annual meeting adds to our confidence in the higher potency of these MSCs, which we expect will result in better outcomes for patients with COVID-19 and ARDS," stated Myron Holubiak, CEO of Citius Pharmaceuticals. "We intend to study these cells in the clinic later this year to determine safety, efficacy, and the optimal dose of these cells in moderate to severe ARDS patients with COVID-19."

https://ir.citiuspharma.com/press-re...mal-stem-cells
antsrants is offline   Rate this post Yes | No Reply With Quote
Reply

Similar Threads
Thread Thread Starter Forum Replies Last Post
Strong Buy: RSL= MC $2 M / Cash $7.7 M / O/S 353 K / Obesity treatment =MEGA Potential Biohero US Penny Stock Picks 2 01-21-2020 08:33 AM
Strong Buy: SKVI H1N1 virus killer current .18 victoria US Penny Stock Picks 25 10-07-2009 11:51 AM
Buy: Taking Cancer Treatment to a New Level (OTC:PVCT) StocksHaven US Penny Stock Picks 3 09-16-2009 09:59 AM
Strong Buy: Taking Cancer Treatment to a New Level (OTC:PVCT) NYPharmer1 US Stock Picks 0 09-16-2009 09:08 AM
Buy: New Pain Treatment Triumphs Morphine (OTC:NPHC) StocksHaven US Penny Stock Picks 0 09-11-2009 02:04 AM


Thread Tools Search this Thread
Search this Thread:

Advanced Search

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is On